Clover Health board member Nathaniel Turner resigns; no disagreement cited

CLOVER HEALTH INVESTMENTS, CORP. /DE

Nathaniel S. Turner resigned from the Board of Directors effective May 26, 2022.
Resignation was not due to any disagreement with the company's operations, policies, or practices.
Turner served for six years; CEO Vivek Garipalli thanked him for being a driving force in founding Clover.
No replacement for the vacant board seat has been announced.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Nathaniel S. Turner

member of the Board of Directors

CLOV · CLOVER HEALTH INVESTMENTS, CORP. /DE

Effective: 2022-05-26
Filed: May 27, 2022, 7:59 PM ET

On May 26, 2022, Nathaniel S. Turner resigned as a member of the Board of Directors of Clover Health Investments, Corp.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Nathaniel S. Turner resigned as member of the Board of Directors at CLOVER HEALTH INVESTMENTS, CORP. /DE.

Action: resigned
Role: member of the Board of Directors

Exact text from the filing

On May 26, 2022, Nathaniel S. Turner resigned as a member of the Board of Directors of Clover Health Investments, Corp.

View on SEC.gov

CLOVER HEALTH INVESTMENTS, CORP. /DE filing history →

Source: SEC EDGAR

accession 0001801170-22-000034

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.